- Encouraging Initial Results to Date in Field Validation Trials
- Toolbox Medical Innovations Engaged for the Design of the Commercial Test Kit
NDA Group Engaged to Assist in Progress Towards CE Marking- Additional International Advisory Board Members:
Paul Field (Australia ) andCharles Pan (Taiwan )
“We are encouraged with the field studies so far, and expanding our global ambitions,” said
Toolbox Medical Innovations will assist with the design of the commercial version of the test kit. Toolbox is an ISO 13485-certified consumables development firm and a full contract research organization (CRO) which develops and manufactures life science and diagnostic products with a focus on in vitro diagnostics (IVD).
Furthermore, to support the company, we are proud to announce an expansion of the Company’s advisory board:
- Mr.
Paul Field was previously with Austrade and has over 30 years of international biotech and, in particular, diagnostics experience. Currently with the Horizon 3Biotech Fund , Strategic Advisor to Alsonex, Marinova and other Australian biotech companies, Paul is the Australian representative for theGeneva -basedGlobal Antibiotic R&D Partnership (GARDP). - Mr.
Charles Pan has over 25 years of professional venture and private equity investment experience inEast Asia andSilicon Valley , and held positions as Chief Executive Officer atOrange Capital , Special Assistant to the Chairman and Investment Director at Foxconn’s mobile business, and Chief Investment Officer atEastern Media Group . His experience covers Investment/M&A, strategic partnership, start-up management and ecosystem building with successful investments in multiple unicorn companies. He was recognized in 2016 and 2017 on the “Powerlist 100” investors by Global Corporate Venturing.
ABOUT
Headquartered in
Through innovations in technology along with the company's unique operating footprint from
For any inquiries regarding Gumnuts or
Further information about
Further information about the Teman Sehat ecosystem can be found at https://www.temansehat.co
Further information about Regenacellex.sl can be found at https://regenacellx.com
Further information about Toolbox can be found here: https://www.toolboxmed.com
Further information about
Investor Relations & Press Contacts:
Investor Relations
Investor Relations
E: ir@achiko.com
Press Contact
E: achiko@farner.ch
T: +41 44 266 67 67
Press Contact
Axel Mühlhaus / Dr
edicto GmbH
E: achiko@edicto.de
T: +49 69 90 55 05-51
DISCLAIMER
This communication expressly or implicitly contains certain forward-looking statements concerning
and other factors, which could cause the actual results, financial condition, performance or achievements of
Source:
2020 GlobeNewswire, Inc., source